DrugDec 6, 2023
Botanical Be Artri King Reforzado con Origa y Omega 3 tablets recall — FDA D-0224-2024
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Class IFDA: OngoingBotanical Be
Latest records
Latest recalls — page 259
The newest recall records with useful source details are listed here.
DrugDec 6, 2023
PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30 recall — FDA D-0130-2024
Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
Class IIFDA: TerminatedGolden State Medical Supply Inc.
DrugDec 6, 2023
Paroxetine Hydrochloride Tablets USP recall — FDA D-0119-2024
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
Class IIFDA: OngoingApotex Corp.
DrugDec 6, 2023
PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30 recall — FDA D-0128-2024
Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
Class IIFDA: TerminatedGolden State Medical Supply Inc.
DrugDec 6, 2023
Paroxetine Hydrochloride Tablets USP recall — FDA D-0121-2024
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
Class IIFDA: OngoingApotex Corp.
VehicleDec 6, 2023
BMW control module (tcm/pcm/tecm) recall — NHTSA campaign 23V821000
BMW of North America, LLC (BMW) is recalling certain 2023 Toyota GR Supra, 3 Series Sedan (330i xDrive, M340i xDrive, M3), 5 Series Sedan (530i, 530i xDrive, M5), 4 Series Gran Coupe (430i,…
control module (tcm/pcm/tecm)BMW of North America, LLC
DrugNov 29, 2023
Exela Pharma Sciences Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL) recall — FDA D-0117-2024
Presence of Particulate Matter: Silicone
Class IFDA: OngoingExela Pharma Sciences LLC
DrugNov 29, 2023
The Harvard Drug Group LLC dba Major Lubricating Tears Eye Drops (Dextran/Hypromellose) recall — FDA D-0108-2024
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class IFDA: TerminatedThe Harvard Drug Group LLC dba Major Pharmaceuticals…
DrugNov 29, 2023
LUBRICANT DROPS LEADER brand Lubricant Eye Drops recall — FDA D-0133-2024
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class IFDA: OngoingCardinal Health Inc.
DrugNov 29, 2023
Cardinal Health LEADER brand Lubricant Eye Drops (Propylene Glycol, 0.6%) recall — FDA D-0136-2024
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class IFDA: OngoingCardinal Health Inc.
DrugNov 29, 2023
Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle recall — FDA D-0112-2024
Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability…
Class IIIFDA: TerminatedGlenmark Pharmaceuticals Inc., USA
DrugNov 29, 2023
DRY EYE RELIEF LEADER brand Dry Eye Relief recall — FDA D-0132-2024
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class IFDA: OngoingCardinal Health Inc.
DrugNov 29, 2023
Integrity Biochem HSC70-LV, Alcohol Antiseptic 70%, Hand Sanitizer, Lavender Scented Topical recall — FDA D-0110-2024
CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.
Class IIFDA: TerminatedIntegrity Bio-Chemicals LLC
DrugNov 29, 2023
Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL (two bottles/300 mL each) recall — FDA D-0115-2024
Failed Viscosity Specifications: Out-of-specification test results for viscosity
Class IIFDA: TerminatedITF PHARMA Inc.
DrugNov 29, 2023
The Harvard Drug Group LLC dba Major Polyvinyl Alcohol 1.4% Lubricating Eye Drops recall — FDA D-0107-2024
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class IFDA: TerminatedThe Harvard Drug Group LLC dba Major Pharmaceuticals…
DrugNov 29, 2023
Integrity Biochem HSC 70-LM, Alcohol Antiseptic 70%, Hand Sanitizer, Lemon Scented Topical recall — FDA D-0109-2024
CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.
Class IIFDA: TerminatedIntegrity Bio-Chemicals LLC
DrugNov 29, 2023
LUBRICANT DROPS LEADER brand Lubricant Eye Drops recall — FDA D-0134-2024
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class IFDA: OngoingCardinal Health Inc.
DrugNov 29, 2023
Buspirone Hydrochloride Tabs USP 10 mg recall — FDA D-0113-2024
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
Class IIIFDA: TerminatedNCS Healthcare of Kentucky Inc.
DrugNov 29, 2023
SODIUM BICARBONATE 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1mEq/mL), a) 20x50 recall — FDA D-0116-2024
Presence of Particulate Matter: Silicone
Class IFDA: OngoingExela Pharma Sciences LLC
DrugNov 29, 2023
Integrity Biochem HSC 70-VA, Alcohol Antiseptic 70%, Hand Sanitizer, Vanilla Scented Topical recall — FDA D-0111-2024
CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.
Class IIFDA: TerminatedIntegrity Bio-Chemicals LLC
DrugNov 29, 2023
EYES IRRITATION RELIEF LEADER brand Eye Irritation Relief recall — FDA D-0131-2024
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class IFDA: OngoingCardinal Health Inc.
DrugNov 29, 2023
DRY EYE RELIEF LEADER brand Dry Eye Relief recall — FDA D-0135-2024
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class IFDA: OngoingCardinal Health Inc.
DrugNov 29, 2023
BUSPIRONE HYDROCHLORIDE Lisinopril Tablets USP 20 mg recall — FDA D-0114-2024
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
Class IIIFDA: TerminatedNCS Healthcare of Kentucky Inc.
DrugNov 29, 2023
ELCYS recall — FDA D-0118-2024
Presence of Particulate Matter: Silicone
Class IFDA: OngoingExela Pharma Sciences LLC
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categories